Pharmacokinetics of cysteine ethyl ester in rat
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 18 (7) , 839-847
- https://doi.org/10.3109/00498258809041722
Abstract
1. The pharmacokinetics of the mucolytic compound 35S-cysteine ethyl ester in rat show that it is completely absorbed after oral administration, with a bioavailability of 0˙59. 2. By autoradiography, tissue distribution of 35S-cysteine ethyl ester showed a high affinity for the lung, different to that observed with 35S-cysteine. 3. Unchanged cysteine ethyl ester, cysteine and inorganic sulphates were present in the lung. 4. After oral or i.v. administration of 35S-cysteine ethyl ester the total radioactivity excreted in the urine amounted to 16% dose and 40% was excreted in the faeces, following biliary excretion. It was metabolized to inorganic sulphate, cysteine and taurine, which were excreted in the urine.This publication has 9 references indexed in Scilit:
- Antigenic and structural features of goblet-cell mucin of human small intestineBiochemical Journal, 1984
- Heterogeneity of rat goblet-cell mucin before and after reductionBiochemical Journal, 1983
- Polymeric structure of pig small-intestinal mucus glycoprotein. Dissociation by proteolysis or by reduction of disulphide bridgesBiochemical Journal, 1981
- Structural studies on gastric mucoproteins: Lowering of molecular weight after reduction with 2-mercaptoethanolBiochemical and Biophysical Research Communications, 1970
- The metabolism of S-methyl-l-cysteineBiochemical Journal, 1968
- Metabolic studies with acetylcysteineBiochemical Pharmacology, 1966
- IN VITRO REDUCTION IN VISCOSITY OF HUMAN TRACHEOBRONCHIAL SECRETIONS BY ACETYLCYSTEINEPublished by Elsevier ,1964
- THE REDUCTION IN VITRO IN VISCOSITY OF MUCOPROTEIN SOLUTIONS BY A NEW MUCOLYTIC AGENT, N‐ACETYL‐L‐CYSTEINEAnnals of the New York Academy of Sciences, 1963
- Techniques and Reagents for Paper ChromatographyAnalytical Chemistry, 1951